Synonyms: Edurant® | TMC-278 | TMC278
rilpivirine is an approved drug (EMA & FDA (2011))
Compound class:
Synthetic organic
Comment: Rilpivirine is an oral non-nucleoside reverse transcriptase inhibitor (NNRTI) HIV medication.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes. EMA (2011) | FDA (2011) |
International Nonproprietary Names ![]() |
|
INN number | INN |
8469 | rilpivirine |
Synonyms ![]() |
Edurant® | TMC-278 | TMC278 |
Database Links ![]() |
|
BindingDB Ligand | 222178 |
CAS Registry No. | 500287-72-9 (source: PubChem) |
ChEMBL Ligand | CHEMBL175691 |
DrugBank Ligand | DB08864 |
GtoPdb PubChem SID | 440816756 |
PubChem CID | 6451164 |
RCSB PDB Ligand | T27 |
Search Google for chemical match using the InChIKey | YIBOMRUWOWDFLG-ONEGZZNKSA-N |
Search Google for chemicals with the same backbone | YIBOMRUWOWDFLG |
Search PubMed clinical trials | rilpivirine |
Search PubMed titles | rilpivirine |
Search PubMed titles/abstracts | rilpivirine |
UniChem Compound Search for chemical match using the InChIKey | YIBOMRUWOWDFLG-ONEGZZNKSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | YIBOMRUWOWDFLG-ONEGZZNKSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Rilpivirine (links to external site)
Cat. No. HY-10574 |